328 related articles for article (PubMed ID: 26439966)
1. Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system.
Macchi B; Marino-Merlo F; Nocentini U; Pisani V; Cuzzocrea S; Grelli S; Mastino A
J Neuroimmunol; 2015 Oct; 287():80-7. PubMed ID: 26439966
[TBL] [Abstract][Full Text] [Related]
2. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL
Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
Akassoglou K; Bauer J; Kassiotis G; Pasparakis M; Lassmann H; Kollias G; Probert L
Am J Pathol; 1998 Sep; 153(3):801-13. PubMed ID: 9736029
[TBL] [Abstract][Full Text] [Related]
4. A 71-year-old male with 4 decades of symptoms referable to both central and peripheral nervous system.
Quan D; Kleinschmidt-DeMasters BK
Brain Pathol; 2005 Oct; 15(4):369-70, 373. PubMed ID: 16389949
[TBL] [Abstract][Full Text] [Related]
5. [The role of the peripheral nervous system damage in clinical picture of multiple sclerosis].
Gusev EI; Lashch NIu; Boĭko AN; Demina TL
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):47-52. PubMed ID: 12938634
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Ellwardt E; Zipp F
Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: a battle between destruction and repair.
McQualter JL; Bernard CC
J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
9. The pathology of multiple sclerosis.
Sobel RA
Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
[TBL] [Abstract][Full Text] [Related]
11. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
12. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system.
't Hart BA; Amor S
Curr Opin Neurol; 2003 Jun; 16(3):375-83. PubMed ID: 12858076
[TBL] [Abstract][Full Text] [Related]
13. New drug therapies for multiple sclerosis.
Mangas A; Coveñas R; Geffard M
Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110
[TBL] [Abstract][Full Text] [Related]
14. The nervous system's potential role in multiple sclerosis associated bone loss.
Josyula S; Mehta BK; Karmon Y; Teter B; Batista S; Ostroff J; Weinstock-Guttman B
J Neurol Sci; 2012 Aug; 319(1-2):8-14. PubMed ID: 22579137
[TBL] [Abstract][Full Text] [Related]
15. Inflammation modulates anxiety in an animal model of multiple sclerosis.
Peruga I; Hartwig S; Thöne J; Hovemann B; Gold R; Juckel G; Linker RA
Behav Brain Res; 2011 Jun; 220(1):20-9. PubMed ID: 21255614
[TBL] [Abstract][Full Text] [Related]
16. The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis.
Kennedy PGE; George W; Yu X
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886931
[TBL] [Abstract][Full Text] [Related]
17. miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.
Wu T; Chen G
Mediators Inflamm; 2016; 2016():4578230. PubMed ID: 27073296
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Mc Guire C; Prinz M; Beyaert R; van Loo G
Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
[TBL] [Abstract][Full Text] [Related]
19. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
